Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure

International Journal of Cardiology

Volumn 171, Issue 3, 2014, Pages 384-389

  Rengo, Giuseppe ^a,b   Pagano, Gennaro ^b   Parisi, Valentina ^b   Femminella, Grazia Daniela ^b   De Lucia, Claudio ^b   Liccardo, Daniela ^b   Cannavo, Alessandro ^b,c   Zincarelli, Carmela ^a   Komici, Klara ^b   Paolillo, Stefania ^b   Fusco, Flavia ^b   Koch, Walter J ^c   Perrone Filardi, Pasquale ^b   Ferrara, Nicola ^a,b   Leosco, Dario ^b  

^a IRCCS   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Exercise training; Heart failure; N terminal pro brain natriuretic peptide; Norepinephrine; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; NORADRENALIN;

AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR MORTALITY; CLINICAL EVALUATION; CLINICAL EXAMINATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; NORADRENALIN BLOOD LEVEL; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYSTOLIC HEART FAILURE;

EXERCISE TRAINING; HEART FAILURE; N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE; NOREPINEPHRINE; PROGNOSIS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NOREPINEPHRINE; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84893699707     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.12.024     Document Type: Article

References (47)

1. J.S. Floras Sympathetic nervous system activation in human heart failure: clinical implications of an updated model J Am Coll Cardiol 54 2009 375 385
2. I.S. Anand, V.G. Florea, and L. Fisher Surrogate end points in heart failure J Am Coll Cardiol 39 2002 1414 1421
3. G. Parati, and M. Esler The human sympathetic nervous system: its relevance in hypertension and heart failure Eur Heart J 33 2012 1058 1066
4. F. Triposkiadis, G. Karayannis, G. Giamouzis, J. Skoularigis, G. Louridas, and J. Butler The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications J Am Coll Cardiol 54 2009 1747 1762
5. G. Rengo, A. Lymperopoulos, and C. Zincarelli et al. Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2)-adrenoceptor- catecholamine production axis in heart failure Br J Pharmacol 166 2012 2430 2440
6. S. Paolillo, G. Rengo, and G. Pagano et al. Impact of diabetes mellitus on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123IMIBG) scintigraphic study Diabetes Care 36 2013 2395 2401
7. H.P. Brunner-La Rocca, M.D. Esler, G.L. Jennings, and D.M. Kay Effect of cardiac nervous activity on mode of death in congestive heart failure Eur Heart J 22 2001 1136 1143
8. J.N. Cohn, T.B. Levine, and M.T. Olivari et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819 823
9. G. Rengo, C. Zincarelli, and G.D. Femminella et al. Myocardial β(2)-adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure Br J Pharmacol 166 2012 2348 2361
10. G. Rengo, P. Perrone-Filardi, and G.D. Femminella et al. Targeting the β-adrenergic receptor system through G-protein-coupled receptor kinase 2: a new paradigm for therapy and prognostic evaluation in heart failure: from bench to bedside Circ Heart Fail 5 2012 385 391
11. N.C. Salazar, X. Vallejos, and A. Siryk et al. GRK2 blockade with betaARKct is essential for cardiac beta2-adrenergic receptor signaling towards increased contractility Cell Commun Signal 11 2013 64
12. T. Tsutamoto, A. Wada, and K. Maeda et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516
13. R. Kazanegra, V. Cheng, and A. Garcia et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study J Card Fail 7 2001 21 29
14. A.M. Richards, I.G. Crozier, T.G. Yandle, E.A. Espiner, H. Ikram, and M.G. Nicholls Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease Br Heart J 69 1993 414 417
15. F. Gustafsson, F. Steensgaard-Hansen, J. Badskjaer, A.H. Poulsen, P. Corell, and P. Hildebrandt Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure J Card Fail 11 2005 S15 S20
16. V. Cheng, R. Kazanagra, and A. Garcia et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study J Am Coll Cardiol 37 2001 386 391
17. A.M. Richards, M.G. Nicholls, and T.G. Yandle et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction: the Christchurch Cardioendocrine Research Group Heart 81 1999 114 120
18. K. Swedberg, P. Eneroth, J. Kjekshus, and L. Wilhelmsen Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality: CONSENSUS Trial Study Group Circulation 82 1990 1730 1736
19. I.S. Anand, L.D. Fisher, and Y.T. Chiang et al. for the Val-HeFT investigators. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan heart failure trial (Val-HeFT) Circulation 107 2003 1278 1283
20. R.T. Yan, M. White, and A.T. Yan et al. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both; for the randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) investigators Am J Cardiol 96 2005 698 704
21. M.R. Bristow, and R. Zelis Baseline and three month change in systemic venous norepinephrine as predictors of clinical outcomes in the BEST Trial investigators J Am Coll Cardiol 37 Suppl. A 2001 183A
22. M.F. Piepoli, C. Davos, D.P. Francis, and A.J. Coats ExTraMATCH Collaborative. Exercise training metaanalysis of trials in patients with chronic heart failure (ExTraMATCH) BMJ 328 2004 189 195
23. D. Leosco, G. Rengo, and G. Iaccarino et al. Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart Cardiovasc Res 78 2008 385 394
24. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC committee for practice guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
25. M.G. Gademan, C.A. Swenne, and H.F. Verwey et al. Effect of exercise training on autonomic derangement and neurohumoral activation in chronic heart failure J Card Fail 13 2007 294 303
26. G. Rengo, D. Leosco, and C. Zincarelli et al. Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure Am J Physiol Heart Circ Physiol 298 2010 H2032 H2038
27. J.N. Cohn Sympathetic nervous system in heart failure Circulation 106 2002 2417 2418
28. G. Rengo, G. Galasso, and G.D. Femminella et al. Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure Eur J Prev Cardiol 21 1 2014 4 11
29. N.A. Smart, and M. Steele Systematic review of the effect of aerobic and resistance exercise training on systemic brain natriuretic peptide (BNP) and N-terminal BNP expression in heart failure patients Int J Cardiol 140 2010 260 265
30. M.F. Piepoli, U. Corrà, and W. Benzer et al. Cardiac rehabilitation section of the European association of cardiovascular prevention and rehabilitation. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation Eur J Cardiovasc Prev Rehabil 17 2010 1 17
31. K. Wasserman, J.E. Hansen, and D.Y. Sue et al. Principles of exercise testing and interpretation 5th ed. 2012 Lippincott Williams & Wilkins Philadelphia
32. D.R. Cox Regression models and life tables J R Stat Soc B 34 1972 187 220
33. P. Royston, and W. Sauerbrei Multivariable model - building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables 2008 John Wiley & Sons 978-0-470-02842-1 64 66
34. F. Giallauria, A. De Lorenzo, and F. Pilerci et al. Reduction of NT-pro-BNP levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction Eur J Cardiovasc Prev Rehabil 13 2006 625 632
35. F. Giallauria, A. De Lorenzo, and F. Pilerci et al. Long-term effects of cardiac rehabilitation on end-exercise heart rate recovery after myocardial infarction Eur J Cardiovasc Prev Rehabil 13 2006 544 550
36. D. Levy, S. Kenchaiah, and M.G. Larson et al. Long-term trends in the incidence of and survival with heart failure N Engl J Med 347 2002 1397 1402
37. V.L. Roger, S.A. Weston, and M.M. Redfield et al. Trends in heart failure incidence and survival in a community-based population JAMA 292 2004 344 350
38. G. Savarese, B. Trimarco, and S. Dellegrottaglie et al. Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials PLoS One 8 3 2013 e58287
39. B.S. Wessler, D.G. Kramer, and J.L. Kelly et al. Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction Circ Heart Fail 4 2011 578 588
40. K. Fox, J.S. Borer, and A.J. Camm et al. Resting heart rate in cardiovascular disease for the Heart Rate Working Group J Am Coll Cardiol 50 2007 823 830
41. E.L. Fosbøl, M. Seibaek, and B. Brendorp et al. Danish Investigations and Arrhythmia ON Dofetilide Study Group. Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: the DIAMOND study Int J Cardiol 140 2010 279 286
42. M. Böhm, K. Swedberg, and M. Komajda et al. SHIFT investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Lancet 376 2010 886 894
43. A.M. Swank, J. Horton, and J.L. Fleg et al. HF-ACTION investigators. Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training Circ Heart Fail 5 2012 579 585
44. D. Dobre, F. Zannad, and S.J. Keteyian et al. Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial Eur Heart J 34 2013 2271 2280
45. L. Frankenstein, C. Zugck, and D. Schellberg et al. Prevalence and prognostic significance of adrenergic escape during chronic beta-blocker therapy in chronic heart failure Eur J Heart Fail 11 2009 178 184
46. J.R. Hampton, D.J. van Veldhuisen, and F.X. Kleber et al. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure: second prospective randomised study of ibopamine on mortality and efficacy (PRIME II) investigators Lancet 349 1997 971 977
47. J. Cohn The MOXCON study Circulation 100 1999 e128